Noah Helman, Ph.D., is a co-founder of Industrial Microbes, a Bay Area synthetic biology startup focused on developing a flexible chemical-manufacturing platform using methane as the raw material. He received his A.B. degree in physics from Harvard University and a Ph.D. in applied physics from Stanford University. He transitioned into the field of synthetic biology as a postdoctoral fellow in the Department of Cellular and Molecular Pharmacology at UC San Francisco. He began his career in industrial biotechnology at LS9 where he developed a directed evolution pipeline by integrating automation, software, and high-throughput wet bench techniques. In 2014, along with Dr. Derek Greenfield and Dr. Elizabeth Clarke, he co-founded Industrial Microbes, where he is responsible for business development, intellectual property, and enzyme engineering.